China SXT Pharmaceuticals (SXTC) Stock Could Be Below Fair Value As Its 100% YTD Slump ContinuesSimplywall·Nov 19, 2026 at 09:18 AMSXTC+2.12%
Innovative drug concept stocks rapidly plummeted, with NEPTUNUS hitting the daily limit, RemeGen falling more than 10%, and many stocks including Cosunter, Rundu Pharma, Sunshine Guojian Pharmaceutical, SL PHARM, and HITECK dropping more than 6%Wallstreetcn·Apr 7, 2026 at 01:41 AM512290-2.26%002038-5.51%
Pharmaceutical commercial stocks are repeatedly active, NEPTUNUS has a 6-day consecutive limit-up, Realcan hits the limit-up, HRPC, SHKK, INT'L GROUP, and others follow suit. In news, China's drug price registration system has officially launchedWallstreetcn·Dec 3, 2025 at 01:53 AM600829-5.73%600272-4.41%
The pharmaceutical commercial sector has seen a short-term surge, with YIXINTANG hitting the limit upZhitong·May 21, 2025 at 01:32 AM000411-2.85%000705-4.75%
NEPTUNUS: NEP018 tablets have received the drug clinical trial approval noticeZhitong·Mar 10, 2025 at 08:31 AM0000780.00%
The pharmaceutical commercial sector is active against the trend, LBX hits the daily limit in the afternoonZhitong·Mar 10, 2025 at 05:34 AM301017-8.64%603939-0.91%
NEPTUNUS expects a pre-loss, with a projected net loss of 950 million to 1.2 billion yuan for the fiscal year 2024Zhitong·Jan 22, 2025 at 09:56 AM0000780.00%
NEPTUNUS: The medical device business is less affected by centralized procurement, and the company's significant matters are still ongoingZhitong·Jan 8, 2025 at 12:24 PM0000780.00%
NEPTUNUS and others established a health technology company, including beverage production businessZhitong·Jan 8, 2025 at 07:12 AM0000780.00%
The pharmaceutical commercial concept fluctuates downward, HRPC approaches the limit downZhitong·Jan 7, 2025 at 05:09 AM300937-6.47%605266-4.57%